| Quarterly Financials | Jun 2024 |
Revenue  | 9 |
| Expenses | 6 |
| EBITDA | 3 |
| Operating Profit % | 30 % |
| Depreciation | 0 |
| Interest | 0 |
| Profit Before Tax | 2 |
| Tax | 1 |
| Net Profit | 1 |
| EPS in ₹ | 24.00 |
Curis Lifesciences
Curis Lifesciences
109.00
-3.95
(-3.50%)
Market Cap
88.12 Cr
PE Ratio
17.04
Volume
7,000.00
Day High - Low
110.25 - 109.00
52W High-Low
147.90 - 83.60
Key Fundamentals
Market Cap
88.12 Cr
EPS
10.26
PE Ratio
17.04
PB Ratio
2.44
Book Value
54.11
EBITDA
11.12
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
37.62
Debt to Equity
1.48
Actual
Company News
View All News
Promoters of Curis Lifesciences declared no new encumbrances on shares for FY26. The disclosure was made under SEBI Takeover Regulations.
Curis Lifesciences reported an 11.4% rise in net profit to ₹691.63 lakh for FY26. Revenue from operations increased 20.6% to ₹6062.88 lakh.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,788.50 | #1 4,29,121.06 | 37.31 | #1 58,220.10 | 6.38 | #1 11,565 | 25.80 | 44.37 | |
6,576.50 | 1,74,585.41 | 67.49 | 10,560.00 | 8.73 | 2,520 | 13.44 | 46.75 | |
4,368.50 | 1,47,849.89 | 68.30 | 13,753.00 | 19.18 | 2,028 | -26.91 | 50.11 | |
1,375.20 | 1,11,086.00 | 28.84 | 27,711.70 | -2.46 | 3,783 | -55.32 | 52.65 | |
1,076.60 | 1,08,331.15 | 21.16 | 26,719.70 | 13.65 | 5,242 | 7.82 | 68.91 | |
1,263.30 | 1,05,440.45 | 25.59 | 33,593.30 | -0.44 | 3,998 | -86.05 | 41.47 | |
2,261.20 | 1,03,346.61 | #1 19.21 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 45.17 | |
2,369.50 | 97,814.16 | 48.97 | 14,277.60 | 12.03 | 1,750 | 31.75 | 50.42 | |
1,440.40 | 83,658.67 | 23.70 | 33,384.70 | 3.21 | 3,376 | 1.99 | 48.90 | |
1,394.30 | 75,272.20 | 83.88 | 6,812.90 | #1 21.03 | 884 | 21.18 | 76.00 |
Growth Rate
Revenue Growth
22.24 %
Net Income Growth
13.61 %
Cash Flow Change
-728.57 %
ROE
-60.11 %
ROCE
-29.27 %
EBITDA Margin (Avg.)
-9.78 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 27 | 30 | 34 | 43 | 82 |
| Fixed Assets | 12 | 12 | 12 | 11 | 12 |
| Current Assets | 15 | 17 | 22 | 31 | 69 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 1 |
| Investments | 0 | 0 | 0 | 0 | 34 |
| Other Assets | 15 | 18 | 22 | 32 | 0 |
| Total Equity & Liabilities | 27 | 30 | 34 | 43 | 82 |
| Current Liabilities | 16 | 19 | 19 | 18 | 27 |
| Non Current Liabilities | 13 | 10 | 10 | 9 | 7 |
| Total Equity | -1 | 0 | 6 | 16 | 47 |
| Reserve & Surplus | -1 | -0 | 5 | 10 | 39 |
| Share Capital | 1 | 1 | 1 | 6 | 8 |
Cash Flow
| Cash Flow | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | 0 | -0 |
| Investing Activities | -0 | -1 | -0 | 0 |
| Operating Activities | 5 | 3 | 0 | -2 |
| Financing Activities | -5 | -3 | 0 | 2 |
Share Holding
| % Holding | Dec 2024 | Jun 2025 | Oct 2025 | Nov 2025 | Mar 2026 |
| Promoter | 92.68 % | 92.68 % | 92.68 % | 68.03 % | 68.03 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 2.93 % | 1.19 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 10.86 % | 5.80 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 4.37 % | 0.00 % | 0.00 % | 13.97 % | 14.38 % |
| Others | 2.95 % | 7.32 % | 7.32 % | 4.20 % | 10.60 % |
| No of Share Holders | 27 | 35 | 36 | 36 | 340 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 04 Dec 2025 |  Quarterly Result Announcement | NA | 04 Dec 2025 | 131.30 | 119.10 |
| 30 May 2026 | Quarterly Result Announcement | NA | 30 May 2026 | 122.00 | 118.00 |
Technical Indicators
RSI(14)
Neutral 39.98
ATR(14)
Less Volatile 4.47
STOCH(9,6)
Oversold 17.93
STOCH RSI(14)
Oversold 0.00
MACD(12,26)
Bearish -2.32
ADX(14)
Strong Trend 34.49
UO(9)
Bearish 45.79
ROC(12)
Downtrend And Accelerating -15.39
WillR(14)
Oversold -95.58
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
